Simmerafil clinical trials
Also written TPN171H.
How each study uses simmerafil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
7 studies that test it; most in 2020 (4)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Studies
Open first, then newest update. How each study uses simmerafil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Long-term Safety of TPN171H Tablet in Erectile Dysfunction.CompletedPhase 3Vigonvita Life SciencesNCT06301854Written as TPN171H
- Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial HypertensionCompletedPhase 2Vigonvita Life SciencesNCT04483115Written as TPN171H
- Safety and Pharmacokinetics of a Single Oral TPN171H in Healthy Elderly SubjectsCompletedPhase 1Vigonvita Life SciencesNCT06090136Written as TPN171H
- Drug-Drug Interaction (DDI) Study for TPN171HCompletedPhase 1Vigonvita Life SciencesNCT06090123Written as TPN171H
- The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial HypertensionCompletedPhase 1Vigonvita Life SciencesNCT05948644Written as TPN171H
- Efficacy and Safety of TPN171H in the Patients With Erectile DysfunctionCompletedPhase 2Vigonvita Life SciencesNCT04479917Written as TPN171H
- Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver FunctionCompletedPhase 1Vigonvita Life SciencesNCT05185011Written as TPN171H